VanEck Pharmaceutical ETF
PPH
#1101
ETF rank
โ‚น111.14 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
โ‚น9,760
Share price
-0.12%
Change (1 day)
33.68%
Change (1 year)

Expense ratio and fees for VanEck Pharmaceutical ETF (PPH)

Expense Ratio

Expense Ratio as of May 2025: 0.36%

Gross Expense Ratio

Gross Expense Ratio as of January 2026: 0.36%

Net Expense Ratio

Net Expense Ratio as of January 2026: 0.36%